Clinical Trial Results: Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining intraoral administration of botulinum toxin for dentoalveolar neuropathic pain has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Botulinum toxin (intraoral administration) (botulinum toxin)

Snippet

Sponsor: Isabel Moreno Hay | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED | Results posted: 2026-07-30